Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Premier Research, BioCentriq Partner on Pre-IND Timelines | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Premier Research, BioCentriq Partner on Pre-IND Timelines

Aims to accelerate the clinical translation of novel cell therapy products.

By: Anthony Vecchione

Premier Research, a global clinical research, product development, and consulting company, and BioCentriq, a contract development and manufacturing organization (CDMO), have entered a strategic partnership to advance the pre-investigational New Drug (IND) process and accelerate the clinical translation of novel cell therapy products.

By leveraging Premier Research’s expertise in cell therapy product development and regulatory expertise, with BioCentriq’s proficiency in developing, manufacturing, and testing cell therapies, the partnership aims to streamline product development from pre-IND through approval.

“Partnering with BioCentriq aligns with our commitment to expediting the development of transformative cell therapies,” said Kenneth Ndugga-Kabuye, vice president, cell, and gene therapy at Premier Research. “By merging our comprehensive product development expertise with BioCentriq’s specialized capabilities we will help sponsors simplify the development process from pre-IND through approval, ultimately accelerating the delivery of innovative therapies to patients in need.”

“This collaboration marks a significant step in fostering a more streamlined pathway for groundbreaking cell therapies,” said Alex Klarer, vice president, business strategy, and innovation at BioCentriq. “Combining Premier Research’s clinical insights with our CDMO expertise will empower us to expedite the translation of novel therapies from the lab to clinical reality, benefiting patients worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics